Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Corporation entities : Apyx medical corporation save search
APYX MEDICAL CORPORATION SHOWCASES NEW DATA AND TREATMENT INSIGHTS AT THE RENUVION USERS’ SUMMIT
Published: 2024-04-11 (Crawled : 12:00) - apyxmedical.com
FNCTF | News | $11.16 130
|
Communications
|
| O: -100.0%
H: NaN%
C: Infinity%
APYX | $1.39 10.32% 43K
|
Health Technology
|
| O: 2.8%
H: 5.44%
C: 5.44%
renuvion corporation treatment medical apyx
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook
Published: 2024-03-21 (Crawled : 13:30) - biospace.com/
APYX | $1.39 10.32% 43K
|
Health Technology
|
| O: -16.22%
H: 0.0%
C: -14.84%
year corporation medical apyx financial
APYX MEDICAL CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS; INTRODUCES FULL YEAR 2024 FINANCIAL OUTLOOK
Published: 2024-03-20 (Crawled : 11:00) - apyxmedical.com
APYX | $1.39 10.32% 43K
|
Health Technology
|
| O: -16.22%
H: 0.0%
C: -14.84%
year corporation medical apyx financial
APYX MEDICAL CORPORATION TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIAL RESULTS ON MARCH 21, 2024
Published: 2024-03-04 (Crawled : 12:30) - apyxmedical.com
APYX | $1.39 10.32% 43K
|
Health Technology
|
| O: 1.92%
H: 8.02%
C: 0.47%
year corporation medical apyx financial results
APYX MEDICAL CORPORATION ANNOUNCES RENUVION TO BE FEATURED IN EDUCATIONAL SESSIONS AT THE AMERICAN ACADEMY OF COSMETIC SURGERY (AACS) SCIENTIFIC MEETING
Published: 2024-02-21 (Crawled : 12:30) - apyxmedical.com
APYX | $1.39 10.32% 43K
|
Health Technology
|
| O: 0.93%
H: 8.3%
C: -7.34%
renuvion corporation sessions meeting medical apyx
APYX MEDICAL CORPORATION ANNOUNCES PEER-REVIEWED CLINICAL PUBLICATION EVALUATING THE SAFETY OF RENUVION FOLLOWING LIPOSUCTION IN MULTIPLE AREAS OF THE BODY
Published: 2024-01-22 (Crawled : 12:30) - apyxmedical.com
APYX | $1.39 10.32% 43K
|
Health Technology
|
| O: 3.52%
H: 5.83%
C: 2.43%
renuvion corporation publication medical apyx
APYX MEDICAL CORPORATION REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2023 REVENUE RESULTS
Published: 2024-01-08 (Crawled : 12:00) - apyxmedical.com
APYX | $1.39 10.32% 43K
|
Health Technology
|
| O: -7.69%
H: 15.29%
C: 5.0%
year corporation revenue medical apyx results
APYX MEDICAL CORPORATION APPOINTS MATTHEW HILL AS CHIEF FINANCIAL OFFICER
Published: 2023-11-28 (Crawled : 14:00) - apyxmedical.com
FNCTF | News | $11.16 130
|
Communications
|
| O: -2.99%
H: 0.0%
C: 0.0%
SSKN | $0.559 5.47% 3.4K
|
Health Technology
|
| O: -4.51%
H: 19.77%
C: 0.23%
PDSB | $3.205 7.19% 630K
|
Health Technology
|
| O: -3.39%
H: 0.7%
C: -6.49%
APYX | $1.39 10.32% 43K
|
Health Technology
|
| O: 0.0%
H: 10.88%
C: 1.02%
corporation medical apyx financial
APYX MEDICAL CORPORATION REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS AND UPDATES FULL YEAR 2023 FINANCIAL OUTLOOK
Published: 2023-11-09 (Crawled : 12:00) - apyxmedical.com
APYX | $1.39 10.32% 43K
|
Health Technology
|
| O: -9.18%
H: 0.0%
C: -12.23%
year corporation medical apyx financial results
APYX MEDICAL CORPORATION ANNOUNCES NEW DEBT FACILITY WITH PERCEPTIVE ADVISORS
Published: 2023-11-09 (Crawled : 12:00) - apyxmedical.com
APYX | $1.39 10.32% 43K
|
Health Technology
|
| O: -9.18%
H: 0.0%
C: -12.23%
corporation medical apyx
APYX MEDICAL CORPORATION TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES IN NOVEMBER
Published: 2023-11-07 (Crawled : 13:00) - apyxmedical.com
APYX | $1.39 10.32% 43K
|
Health Technology
|
| O: 0.39%
H: 17.19%
C: -0.39%
corporation medical apyx
APYX MEDICAL CORPORATION TO RELEASE THIRD QUARTER OF FISCAL YEAR 2023 FINANCIAL RESULTS ON NOVEMBER 9, 2023
Published: 2023-10-02 (Crawled : 12:00) - apyxmedical.com
APYX | $1.39 10.32% 43K
|
Health Technology
|
| O: -0.94%
H: 0.69%
C: -4.73%
year corporation medical apyx financial results
APYX MEDICAL CORPORATION REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS AND REAFFIRMS FULL YEAR 2023 FINANCIAL OUTLOOK
Published: 2023-08-10 (Crawled : 20:00) - apyxmedical.com
APYX | $1.39 10.32% 43K
|
Health Technology
|
| O: 0.46%
H: 2.5%
C: -4.43%
year corporation medical apyx financial results
APYX MEDICAL CORPORATION TO RELEASE SECOND QUARTER OF FISCAL YEAR 2023 FINANCIAL RESULTS ON AUGUST 10, 2023
Published: 2023-06-29 (Crawled : 20:00) - apyxmedical.com
FNCTF | News | $11.16 130
|
Communications
|
| O: 0.95%
H: 0.0%
C: 0.0%
APYX | $1.39 10.32% 43K
|
Health Technology
|
| O: -0.26%
H: 2.25%
C: -11.49%
year corporation medical apyx financial results
APYX MEDICAL CORPORATION ANNOUNCES FDA 510(K) CLEARANCE FOR THE RENUVION MICRO HANDPIECE
Published: 2023-06-14 (Crawled : 12:00) - apyxmedical.com
APYX | $1.39 10.32% 43K
|
Health Technology
|
| O: 8.09%
H: 0.13%
C: -7.75%
fda renuvion corporation clearance medical apyx
APYX MEDICAL CORPORATION REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND UPDATES FULL YEAR 2023 FINANCIAL OUTLOOK
Published: 2023-05-11 (Crawled : 11:00) - apyxmedical.com
APYX | $1.39 10.32% 43K
|
Health Technology
|
| O: 0.57%
H: 28.0%
C: 28.0%
year corporation medical apyx financial results
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® for Coagulation of Subcutaneous Soft Tissues Following Liposuction for Aesthetic Body Contouring
Published: 2023-04-28 (Crawled : 12:00) - biospace.com/
APYX | $1.39 10.32% 43K
|
Health Technology
|
| O: 10.26%
H: 9.91%
C: 2.1%
renuvion fda aesthetic corporation clearance medical apyx
APYX MEDICAL CORPORATION TO RELEASE FIRST QUARTER OF FISCAL YEAR 2023 FINANCIAL RESULTS ON MAY 11, 2023
Published: 2023-04-05 (Crawled : 20:00) - apyxmedical.com
FNCTF | News | $11.16 130
|
Communications
|
| O: -0.36%
H: 0.0%
C: 0.0%
APYX | $1.39 10.32% 43K
|
Health Technology
|
| O: 0.7%
H: 3.39%
C: 2.37%
year corporation medical apyx financial results
APYX MEDICAL CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS; INTRODUCES FULL YEAR 2023 FINANCIAL OUTLOOK
Published: 2023-03-16 (Crawled : 11:00) - apyxmedical.com
APYX | $1.39 10.32% 43K
|
Health Technology
|
| O: 0.38%
H: 12.17%
C: 10.27%
year corporation medical apyx financial
APYX MEDICAL CORPORATION RECEIVES FDA 510(K) CLEARANCE FOR THE USE OF RENUVION TO COAGULATE AND CONTRACT SOFT TISSUES, INCLUDING SUBCUTANEOUS TISSUE, WHERE NEEDED
Published: 2023-02-27 (Crawled : 13:00) - apyxmedical.com
APYX | $1.39 10.32% 43K
|
Health Technology
|
| O: 4.18%
H: 4.01%
C: 2.01%
fda clearance medical apyx renuvion contract corporation
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.56 162.07% 21M
|
AGBA | $2.74 119.2% 52M
|
Finance
CZOO | $9.07 81.76% 22M
|
EDBL | News | $6.56 74.47% 1.8M
|
OPRT | News | $3.37 49.78% 8.9M
|
Finance
MTC | $2.21 41.67% 5.6M
|
Technology Services
VNRX | $0.7945 32.42% 3.1M
|
Health Technology
MLEC | $1.81 29.29% 2.8M
|
n/a
BTCM | $3.45 27.78% 640K
|
Arts, Entertainment, and Recrea...
PALI | $6.29 27.59% 22M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.